skip to content
Local drug delivery for coronary artery disease Preview this item
ClosePreview this item

Local drug delivery for coronary artery disease

Author: Edoardo Camenzind; Ivan K De Scheerder
Publisher: London ; New York : Taylor & Francis, 2005.
Edition/Format:   Print book : EnglishView all editions and formats
Pioneers in the field, the authors have assembled an excellent team of contributors to offer their experience on threatened vessel closure and restenosis, acute thrombosis, hyperproliferative cellular response, stents and local drug delivery.

(not yet rated) 0 with reviews - Be the first.

More like this


Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...


Genre/Form: Case Reports
Document Type: Book
All Authors / Contributors: Edoardo Camenzind; Ivan K De Scheerder
ISBN: 9781841840451 1841840459
OCLC Number: 47272527
Description: xiii, 594 pages : illustrations (some color) ; 26 cm
Contents: GENERAL INTRODUCTION Introduction Purposes of the Site-specific Therapy: Arterial Wall Passivation Local Drug Delivery: Impact of Pressure, Substance Characteristics and Stenting on Drug Transfer Into the Arterial Wall SYLLABUS OF THE PLATFORMS FOR LOCAL VASCULAR DRUG DELIVERY Catheter-based and Stent-based Treatment for Coronary Artery Disease The ClearWay(TM) Microporous Balloon Catheter DISPATCH(R) Coronary Infusion Catheter REMEDY(TM) PTCA Dilation Infusion Catheter Infiltrator angioplasty Balloon Catheter The Infiltrator(TM) Local Drug Delivery Catheter The Needle Catheter Stent Mediated Local Drug Delivery INERT AND NON-ELUTING COATINGS Silicon Carbide-coated Stents Carbostent: A Carbofilm(TM) Coated Stent The PC-coated BiodivYsio(TM) Stent PTFE Covered Stent DRUG ELUTING COATINGS Overview about Drug Delivery Coatings Phosphorylocholine (PC Technology(TM)) Coated stents as a Drug Delivery Platform Direct Stent Coating: An Alternative for Polymers? Radioactive Stents SYLLABUS OF THERAPEUTIC AGENTS Overview of Potential Interesting Drugs to Inhibit in-stent Restenosis Direct Antithrombins Tissue Factor Inhibitors Nitric Oxide Related Interventions and Restenosis Vitamin E and its Multiple Properties: Anti, Pro, and Non-oxidative Activities Dexamethasone Eluting Stent Anti-inflammatory Approaches to Restenosis The Role of Matrix Metalloproteinases Inhibitors after Arterial Injury Methotrexate: A Potential Interesting Drug for Stent Mediated Local Drug Delivery anti-inflammatory and anti Proliferative Characteristics Actin-skeleton Inhibitors: Poetential Candidates for Local Drug Delivery in the Prevention of an In-stent Restenosis? Local Delivery of Antisense Oligomers to c-myc for the Prevention of Restenosis PRE-CLINICAL STUDIES Character-based Intravascular Delivery Stent-based Intravascular Delivery CLINICAL STUDIES Catheter-based Local Heparin Delivery Local Delivery of Low Molecular Weight Heparins Local Delivery of Steroids before Coronary Stent Implantation Clinical Studies with the Carbostent Gold Coated Stents Heparin-coated Stent trials The Blue Medical 50% TEMPO Coronary Stent: Pre-clinical Study and the First In-man Pilot Trial Dexamethasone: Mode of action, Pre-clinical and Clinical Studies ss-edstradiol Eluting Stents - A Potential Therapy in the Prevention of Restenosis Batimastat: Mode of Action, Preclinical and Clinical Studies FIM Trial Tacrolimus Eluting Stents Everolimus Eluting Stents Endeavor Drug-eluting Stent Systems The Quanam Drug-eluting Stent and the SCORE Trial The Boston Scientific Paclitaxel-eluting Stent: TAXUS I and II Clinical Results with Non-polymer Based Taxol-eluting Stents: The European EvaLUation of pacliTaxel Eluting Stent (ELUTES) Trial ALTERNATIVE METHODS FOR LOCAL VCASCULAR DRUG DELIVERY Intrapericardial Drug Delivery for Prevention of Restenosis Alternatives to Drug-eluting Stents: Safety and Efficacy of Systemic Delivery of Anti-proliferative Therapy to Reduce In-stent Neointimal Hyperplasia LOCAL DRUG DELIVERY: A CRITICAL PERSPECTIVE Drug-eluting Stents: A Critical Perspective
Responsibility: [edited by] Edoardo Camenzind, Ivan K. de Scheerder.


Local Drug Delivery for Coronary Artery Disease 


User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...


Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data

Primary Entity

<> # Local drug delivery for coronary artery disease
    a schema:Book, schema:CreativeWork ;
   library:oclcnum "47272527" ;
   library:placeOfPublication <> ; # London
   library:placeOfPublication <> ; # New York
   library:placeOfPublication <> ;
   schema:about <> ; # Drug Delivery Systems--instrumentation
   schema:about <> ; # Stents (Surgery)
   schema:about <> ; # Coronary Disease--therapy
   schema:about <> ; # Drug Delivery Systems--methods
   schema:about <> ; # Drug delivery systems
   schema:about <> ;
   schema:about <> ; # Drug Administration Routes
   schema:about <> ; # Médicaments--Administration--Dispositifs
   schema:bookFormat bgn:PrintBook ;
   schema:contributor <> ; # Ivan K De Scheerder
   schema:contributor <> ; # Edoardo Camenzind
   schema:datePublished "2005" ;
   schema:description "Pioneers in the field, the authors have assembled an excellent team of contributors to offer their experience on threatened vessel closure and restenosis, acute thrombosis, hyperproliferative cellular response, stents and local drug delivery."@en ;
   schema:exampleOfWork <> ;
   schema:genre "Case Reports"@en ;
   schema:inLanguage "en" ;
   schema:name "Local drug delivery for coronary artery disease"@en ;
   schema:productID "47272527" ;
   schema:publication <> ;
   schema:publisher <> ; # Taylor & Francis
   schema:workExample <> ;
   umbel:isLike <> ;
   umbel:isLike <> ;
   wdrs:describedby <> ;

Related Entities

<> # London
    a schema:Place ;
   schema:name "London" ;

<> # New York
    a schema:Place ;
   schema:name "New York" ;

<> # Taylor & Francis
    a bgn:Agent ;
   schema:name "Taylor & Francis" ;

<> # Coronary Disease--therapy
    a schema:Intangible ;
   schema:name "Coronary Disease--therapy"@en ;

<> # Drug Administration Routes
    a schema:Intangible ;
   schema:name "Drug Administration Routes"@en ;

<> # Drug Delivery Systems--instrumentation
    a schema:Intangible ;
   schema:name "Drug Delivery Systems--instrumentation"@en ;

<> # Drug Delivery Systems--methods
    a schema:Intangible ;
   schema:name "Drug Delivery Systems--methods"@en ;

<> # Médicaments--Administration--Dispositifs
    a schema:Intangible ;
   schema:name "Médicaments--Administration--Dispositifs"@fr ;

<> # Stents (Surgery)
    a schema:Intangible ;
   schema:name "Stents (Surgery)"@en ;

<> # Drug delivery systems
    a schema:Intangible ;
   schema:name "Drug delivery systems"@en ;

<> # Edoardo Camenzind
    a schema:Person ;
   schema:familyName "Camenzind" ;
   schema:givenName "Edoardo" ;
   schema:name "Edoardo Camenzind" ;

<> # Ivan K De Scheerder
    a schema:Person ;
   schema:familyName "Scheerder" ;
   schema:givenName "Ivan K. De" ;
   schema:name "Ivan K De Scheerder" ;

    a schema:ProductModel ;
   schema:isbn "1841840459" ;
   schema:isbn "9781841840451" ;

Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.